🇺🇸 FDA
Patent

US 10023848

Immunogenic composition comprising Panton-Valentine Leukocidin (PVL) derived polypeptides

granted A61KA61K2039/505A61K2039/55505

Quick answer

US patent 10023848 (Immunogenic composition comprising Panton-Valentine Leukocidin (PVL) derived polypeptides) held by INTEGRATED BIOTHERAPEUTICS, INC. expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
INTEGRATED BIOTHERAPEUTICS, INC.
Grant date
Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/505, A61K2039/55505, A61K2039/55561, A61K2039/55566